Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms
Authors:
- Giuliana Galli CarminatiGCGiuliana Galli Carminati
- Nicolas DeriazNDNicolas Deriaz
- Gilles BertschyGBGilles Bertschy
- 1 March 2006
- journal article
- case report
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 30 (2) , 312-315
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Autism as a disorder of neural information processing: directions for research and targets for therapyMolecular Psychiatry, 2004
- Association of autism severity with a monoamine oxidase A functional polymorphismClinical Genetics, 2003
- Role of altered brain serotonin mechanisms in autismMolecular Psychiatry, 2002
- Evidence of the Dual Mechanisms of Action of VenlafaxineArchives of General Psychiatry, 2000
- Venlafaxine in Children, Adolescents, and Young Adults With Autism Spectrum Disorders: An Open Retrospective Clinical ReportJournal of Child Neurology, 2000
- Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline‐ and methoxamine‐evoked constriction of the dorsal hand veinBritish Journal of Clinical Pharmacology, 1999
- Paroxetine Treatment of Aggression and Self-Injury in Persons With Mental RetardationAmerican Journal on Mental Retardation, 1997
- Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disordersJournal of Autism and Developmental Disorders, 1994
- Fluoxetine Treatment of Children and Adults with Autistic Disorder and Mental RetardationJournal of the American Academy of Child & Adolescent Psychiatry, 1992
- CSF Monoamines in Autistic Syndromes and Other Pervasive Developmental Disorders of Early ChildhoodThe British Journal of Psychiatry, 1987